Literature DB >> 11750331

Optimization of cyclosporine exposure utilizing C(2) level monitoring in de novo renal transplant recipients: the Toronto General Hospital experience.

N Maham1, C Cardella, D Cattran, S Fenton, C O'Grady, J Hamill, R Smith, E Cole.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11750331     DOI： 10.1016/s0041-1345(01)02320-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Advantages of cyclosporin A using 2-h levels in pediatric kidney transplantation.

Authors:  Lars Pape; Jochen H H Ehrich; Gisela Offner
Journal:  Pediatr Nephrol       Date:  2004-07-10       Impact factor: 3.714

2.  Utility of C-2 (Cyclosporine) monitoring in postrenal transplant patients: A study in the Indian population.

Authors:  V Thakur; R Kumar; P N Gupta
Journal:  Indian J Nephrol       Date:  2008-07

3.  [Significance of cyclosporin A absorption for effective immunomodulatory therapy after high-risk keratoplasty].

Authors:  N Bailly; I Dunewa; P Schlattmann; P W Rieck
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.